Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
75°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Global Blood Ther
(NQ:
GBT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 4, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
68.47 (25)
Ask (Size)
68.49 (90)
Prev. Close
68.49
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
67,463,704
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech Stocks Well-Positioned For The Fourth Quarter
October 12, 2022
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Via
Talk Markets
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
September 20, 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.
Via
Talk Markets
Performance
More News
Read More
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
Via
Investor's Business Daily
Global Blood Therapeutics's Return On Capital Employed Overview
September 15, 2022
Via
Benzinga
Where Global Blood Therapeutics Stands With Analysts
August 09, 2022
Via
Benzinga
Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics
August 08, 2022
Via
Investor's Business Daily
Pfizer Scoops Up Sickle Disease Player For $5B
August 08, 2022
Via
Benzinga
Global Blood Therapeutics's Return On Capital Employed Overview
September 01, 2022
Via
Benzinga
After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal
September 01, 2022
Via
Benzinga
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
August 31, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
Via
Investor's Business Daily
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million
August 23, 2022
Via
Investor's Business Daily
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
August 12, 2022
Via
Investor's Business Daily
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US
August 09, 2022
Via
Benzinga
8 Analysts Have This to Say About Global Blood Therapeutics
August 09, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
August 09, 2022
Via
Benzinga
Global Blood Therapeutics: Q2 Earnings Insights
August 08, 2022
Via
Benzinga
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
August 08, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal
August 08, 2022
Via
Benzinga
TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week
August 08, 2022
Via
InvestorPlace
GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics
August 08, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
Global Blood (GBT) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Global Blood Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GBT
August 08, 2022
From
Halper Sadeh LLP
Via
Business Wire
Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8
August 08, 2022
Via
Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
August 08, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.